Quarterly report pursuant to Section 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
Condensed Balance Sheets
Condensed Balance Sheets (Parenthetical)
Condensed Statements of Operations
Condensed Statements of Stockholders' Equity
Condensed Statements of Cash Flow
Notes to Financial Statements
Organization, Description of Business and Liquidity and Capital Resources
Significant Accounting Policies
License, Clinical Trial and Sponsored Research Agreements
Related Party Agreements
Property and Equipment
Commitments and Contingencies
Notes Payable
Leases
Stockholders' Equity
Net Loss per Share
Accounting Policies
Significant Accounting Policies (Policies)
Notes Tables
License, Clinical Trial and Sponsored Research Agreements (Tables)
Property and Equipment (Tables)
Notes Payable (Tables)
Leases (Tables)
Stockholders' Equity (Tables)
Net Loss per Share (Tables)
Notes Details
Organization, Description of Business and Liquidity and Capital Resources (Details)
Significant Accounting Policies (Details)
License, Clinical Trial and Sponsored Research Agreements - Licenses (Details)
License, Clinical Trial and Sponsored Research Agreements - Sponsored (Details)
Related Party Agreements (Details)
Property and Equipment (Details)
Property and Equipment - Additional Information (Details)
Notes Payable (Details)
Notes Payable - Additional Information (Details)
Leases (Details)
Leases - Cash flows (Details)
Leases - Maturities of operating leases (Details)
Leases - Future minimum lease payments (Details)
Leases - Additional Information (Details)
Stockholders' Equity (Details)
Stockholders' Equity - Stock Awards - Options (Details)
Stockholders' Equity - Option activity and Unrecognized expense (Details)
Stockholders' Equity - Restricted stock and RSUs (Details)
Stockholders' Equity - Stock-based compensation expense (Details)
Stockholders' Equity - Warrants (Details)
Net Loss per Share (Details)
Leases - Future minimum lease payments (Details)